Impact of socioeconomic and cardiovascular risk factors on the effect of genetic variants associated with NT-proBNP

被引:0
|
作者
Emanuel Matusch
Mirjam Frank
Kaffer Kara
Amir A. Mahabadi
Nico Dragano
Raimund Erbel
Karl-Heinz Jöckel
Börge Schmidt
机构
[1] University of Duisburg-Essen,Institute for Medical Informatics, Biometry and Epidemiology
[2] Agaplesion Hospital Hagen,Department of Cardiology
[3] University of Duisburg-Essen,West German Heart and Vascular Center Essen, Department of Cardiology and Vascular Medicine, University Hospital Essen
[4] University Hospital Düsseldorf,Institute of Medical Sociology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
N-terminal prohormone of brain natriuretic peptide (NT-proBNP) is an established biomarker for diagnosis of heart failure. The study aims to explore whether known cardiovascular risk factors, including education and income as indicators of socioeconomic position (SEP), may interact with the genetic effect of NT-proBNP-related single nucleotide polymorphisms (SNP) to influence plasma levels of NT-proBNP in a population-based study sample. Information on effect alleles of three SNPs previously reported to be related to NT-proBNP was combined individually for 4,520 participants of the Heinz Nixdorf Recall Study to calculate a genetic risk allele sum score (GRSNT-proBNP). Linear Regression models were used to examine the association of cardiovascular risk factors and GRSNT-proBNP with log-transformed NT-proBNP levels, as well as cardiovascular risk factor by GRSNT-proBNP interactions. The GRSNT-proBNP was associated with NT-proBNP showing 1.13-fold (95% CI 1.10–1.16) higher plasma levels per additional effect allele. Interaction terms included in the regression models gave some indication for interaction of the GRSNT-proBNP with the SEP indicator income as well as with C-reactive protein. In regression models stratified by income quartiles the strongest genetic effect was observed in the third income quartile showing 1.18-fold (95% CI 1.12–1.25) higher average NT-proBNP levels per additional allele compared to the lowest income quartile with 1.08-fold (95% CI 1.01–1.15) higher NT-proBNP levels. The results of the present study indicate that genetic effects of NT-proBNP increasing alleles are stronger in higher SEP groups. This may be due to a stronger influence of non-genetic cardiovascular risk on NT-proBNP in low SEP groups.
引用
收藏
相关论文
共 50 条
  • [21] Can NT-proBNP monitoring help prevent cardiovascular disease?
    Campbell, D. J.
    Woodward, M.
    Chalmers, J. P.
    Colman, S. A.
    Jenkins, A. J.
    Kemp, B. E.
    Neal, B. C.
    Patel, A.
    MacMahon, S. W.
    RECENT ADVANCES IN CARDIOVASCULAR DISEASE: PROCEEDINGS OF THE 13TH WORLD CONGRESS HEART DISEASE, 2007, : 331 - +
  • [22] NT-proBNP in "low risk" patients with atrial fibrillation
    Kornej, Jelena
    Loebe, Susanne
    Efimova, Elena
    Husser, Daniela
    Hindricks, Gerhard
    Bollmann, Andreas
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 179 : 493 - 494
  • [23] NT-proBNP and metabolic risk factors in two ethnic groups - The SABPA cohort study
    Jujic, A. Amra
    Melander, O.
    Nilsson, P. M.
    Malan, L.
    Fedorowski, A.
    Magnusson, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 322 - 322
  • [24] Rationale for the testingof cardiovascular risk in patients with COX-2 inhibitors with the biomarker NT-proBNP
    Giannitsis, E
    CLINICAL LABORATORY, 2005, 51 (1-2) : 73 - 83
  • [25] Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis Patients
    Pastural-Thaunat, M.
    Ecochard, R.
    Boumendjel, N.
    Abdullah, E.
    Cardozo, C.
    Lenz, A.
    M'Pio, I.
    Szelag, J. C.
    Fouque, D.
    Walid, A.
    Laville, M.
    NEPHRON EXTRA, 2012, 2 (01): : 311 - 318
  • [26] Relationships between NT-proBNP and novel biochemical parameters and increased cardiovascular risk in COVID-19 NT-proBNP levels and novel inflammatory biomarkers in COVID-19
    Altinbas, Ozgur
    Mete, Ayse Ozlem
    Demiryurek, Seniz
    Hafiz, Erhan
    Saracaloglu, Ahmet
    Demiryurek, Abdullah Tuncay
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2021, 12 : 529 - 533
  • [27] The predictive value of elevated NT-proBNP and BNP for mortality in the absence of cardiovascular risk factors or structural cardiac abnormalities in the general community
    Mckie, P. M.
    Rodeheffer, R.
    Mahoney, D.
    Cataliotti, A.
    Jacobsen, S.
    Redfield, M.
    Burnett, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 127 - 128
  • [28] The Effect of Renal Dysfunction on BNP, NT-proBNP, and Their Ratio
    Srisawasdi, Pornpen
    Vanavanan, Somlak
    Charoenpanichkit, Charaslak
    Kroll, Martin H.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (01) : 14 - 23
  • [29] Can NT-proBNP improve the diagnosis of angiogenic factors for preeclampsia?
    Garrido-Gimenez, C.
    Cruz-Lemini, M.
    Nan, M. N.
    Mora-Burgues, J.
    Garcia-Manau, P.
    Ullmo, U.
    Sanchez-Garcia, O.
    Garcia-Osuna, A.
    Llurba, E.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54
  • [30] Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study
    Tcheugui, Justin Basile
    Zhang, Sui
    McEvoy, John William
    Ndumele, Chiadi E.
    Hoogeveen, Ron C.
    Coresh, Josef
    Selvin, Elizabeth
    AMERICAN JOURNAL OF MEDICINE, 2022, 135 (12): : 1461 - 1467